The synthesis of a gene coding for horseradish peroxidase (HRP, isozyme c; EC 1.11
fragments, in-frame, by using the PCR was also developed and used to synthesize the HRP gene from its gene fragments. This method is applicable to the synthesis of even larger genes and to combine any DNA fragments in-frame. After the synthesis, preliminary characterization of the HRP gene was also carried out by the PCR to confirm the arrangement of oligonucleotides in the gene. This was done by carrying out the PCR with several sets of primers along the gene and comparing the product sizes with the expected sizes. The gene and the fragments generated by PCR were cloned in Escherichia coil and the sequence was confirmed by manual and automated DNA sequencing.
Horseradish peroxidase (HRP, EC 1.11.1.7) catalyzes the oxidation of a variety of reductants by hydrogen peroxide. It is used clinically, in enzyme immunoassays, and in histological chemistry as a protein tracer. HRP consists of several isozymes (1) as analyzed by their behavior in isoelectric focusing. The complete primary structure ofone of the neutral isozymes (isozyme c) was established by Welinder (2, 3) . This isozyme was also identified to be involved in the electron-transfer mechanism and the binding to protoheme and the substrate. However, the structure-function relationship of HRP has not been understood because of the difficulty in obtaining large quantities of a single pure isozyme.
We undertook the synthesis, cloning, and expression of a gene for HRP isozyme c for this purpose. Engineering specific properties of the enzyme may also be possible subsequently. The gene coding for the enzyme was obtained by a polymerase chain reaction (PCR)-mediated gene synthesis strategy (4) . This report provides details of the strategy and also introduces a general procedure to join DNA fragments in-frame. 1 ,uCi/,ul; 1 Ci = 37 GBq) were used excluding unlabeled ATP. For ligations, several oligonucleotides were annealed simultaneously. Twelve to 40 oligonucleotides making up either parts of the gene or the whole gene were pooled, heated to 95°C for 5 min, and then slow cooled to room temperature over a period of about 1.5 h. After cooling, a fresh solution of 10 mM ATP and 100 mM dithiothreitol was added to final concentrations of 1 mM ATP and 10 mM dithiothreitol. Two to 10 units of T4 DNA ligase was added and incubated either at room temperature for 2 h or at' 12C overnight. For PCR amplifications, the ligation mixture was diluted 1:10 to 1:250. Alternatively, only 0.25 pmol of oligonucleotides was annealed and ligated in a total volume of5-10 ,ul and used directly for the PCR.
MATERIALS AND METHODS
PCRs. All the PCRs were carried out by using the DNA thermal cycler (Perkin-Elmer). After investigating several reaction conditions, we arrived at the following optimal conditions. The reaction buffer contained 50 mM KCI, 10 mM Tris Cl (pH 8.0), all four deoxyribonucleoside triphosphate (each at 500 mM hereafter referred to as 500 mM dNTPs), 2.5 mM MgCl2, and gelatin (100 ,ug/ml). The reaction conditions were 1.0 min at 94°C, 30 sec at 55°C, and 45 sec at 70°C. Taq polymerase (2-5 units) was used in a total reaction volume of 50 or 100 ,ul. The primer concentrations were 1 puM. Generally, 30 cycles of amplifications were carried out. The length of oligonucleotide primers was 20-52 bases long depending on the strategy used for constructing the gene. The primers used for the PCR were only purified by gel filtration. PCR products were analyzed on a 4% (wt/vol) agarose (3% NuSieve/1% SeaKem) gel.
Centricon Filtrations. Centricon filtrations were carried out essentially as described (6) . A Centricon-30 was used pre-
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dominantly except for ligation mixtures containing all 40 oligonucleotides where a Centricon-100 was also used. Ligation or PCR mixtures were diluted to 2 ml with 1x TE (10 mM Tris HCl, pH 7.6/1 mM EDTA) and centrifuged at 2000 x g (1000 x g for Centricon-100) for 20-30 min. Centrifugation was carried out with another 500 1Lp of 1x TE. The sample reservoir was turned upside down and centrifuged for 15 min to collect the retentate. One to 5 gl of the retentate was used directly for PCR.
HRP Gene Synthesis from its Fragments and the Design of Oligonucleotides for the PCR. The two end oligonucleotides, HRP1 (52-mer) and HRP40 (36-mer), of the HRP gene were used as primers (without modification in length or sequence) for the amplification of the gene from the ligation or PCR mixtures. To amplify HRP gene fragments and to subsequently assemble the gene in-frame, we introduced a Fok I restriction enzyme recognition sequence at the 5' end of the primers. The Fok I sequence is preceded at least by one additional random base to ensure recognition and cleavage of the PCR product by this enzyme. These primers were usually 37-42 bases long. The first 15 bases constitute the Fok I recognition-cleavage sequence and the rest is from the HRP sequence. Between the recognition and the cleavage sites, other restriction enzyme recognition sites (such as EcoRI and BamHI) were introduced to facilitate cloning. PCRs were carried out as described earlier. The PCR mixtures were first ethanol-precipitated and then treated with 2 units of Fok I in 20 ul containing 20 mM KCI, 10 mM Tris HCl (pH 7.5), 10 mM MgCG2, 10 mM 2-mercaptoethanol, and bovine serum albumin (100 ,g/ml) for 2 h at 370C. The reaction mixtures were then electrophoresed on a 4% NuSieve gel (low melting) and the product bands were excised, melted, phenolextracted, and ethanol-precipitated. Finally, they were dissolved in 10 ul of 1 x TE. Each fragment (5 pl) was used for ligation in a total volume of 20 ,ul containing 2 units of T4 DNA ligase. Ligation was carried out at room temperature for 2 h. The ligation mixture (5 ,ul) was checked by electrophoresis on a 4% NuSieve gel.
Another strategy for constructing the HRP gene from its fragments was to use overlapping oligonucleotides to connect two PCR-amplified fragments in-frame. Fragments 1, 2, and 3 were ligated individually using 25 pmol of HRP oligonucleotides 1-14, 13-26, and 25-40, respectively, as described earlier. Since oligonucleotides 13 and 14 are present in both fragments 1 and 2, PCR amplification (after ligation) using primers 1 and 26 would result in precise fusion of fragments 1 and 2. Similarly, since the oligonucleotides 25 and 26 are present in both fragments 2 and 3, PCR amplification (after ligation) using primers 13 and 40 would produce fusion of these two fragments in-frame. The entire gene can be amplified in-frame by combining all the three individually ligated fragments using primers 1 and 40. Oligonucleotides (5 pmol) 1-14, 13-26, and 25-40 were ligated in a total volume of 20 ,ul as described before. Each ligation mixture (1 ,u) was combined and used as the target for PCR. HRP1 and HRP40 were used as primers. PCR conditions were as described before. Alternatively, each of these individual groups was PCR-amplified first for 10-15 cycles and 1 ,u of the PCR mixtures (after Centricon-30 filtrations) was combined and used for PCR amplification (30 cycles) of the gene.
Characterization of HRP Gene by PCR. A 0.5-,ul sample from a stock solution of 20 ,ul of HRP gene was used as the target. If the gene was present in a low-melting-point gel, 2-5 ,u from a total of 50 ,ul was used. By using the conditions described earlier and several sets of primers, the PCR was carried out for 30 cycles. The PCR products were analyzed on a 4% gel containing 3% NuSieve and 1% SeaKem. The product bands were visualized with long-wavelength UV lamp after staining with ethidium bromide.
Cloning and Sequencing Analysis. The PCR products were purified on a low-melting-point gel after treatment with EcoRI and BamHI. Cloning and transformations were carried out using standard procedures (17) . Manual double-stranded sequencing was performed as described (7) . Taq polymerase was used for double-stranded sequencing on an Applied Biosystems model 370A sequencer using a procedure supplied along with the sequencing kit.
RESULTS
Design of the Synthetic Gene. HRP isozyme c contains 308 amino acid residues, eight neutral carbohydrate side chains (glycosylation sites), and four disulfide bridges. It seemed obvious to us that, to obtain an active protein, proper posttranslational modifications and folding are essential, and so we investigated the expression of the synthetic gene in a variety of hosts, such as Escherichia coli, Bacillus subtilis, and yeast. Since there appears to be a relationship between expression and the usage of codons in a gene (8) , the HRP gene was designed using preferred codons common to all the three organisms. The next best codon was used when there was a conflict. Based on these considerations, our codon usage was as follows: alanine, GCT/GCC; arginine, AGA; asparagine, AAC; aspartic acid, GAC/GAT; cysteine, TGT; glutamine, CAG; glutamic acid, GAA; glycine, GGT; histidine, CAC; isoleucine, ATT/ATC; leucine, TTG; lysine, AAG; phenylalanine, TTC; proline, CCA/CCT; serine, TCT/TCC/AGC; threonine, ACC/ACT; tyrosine, TAC/ TAT; valine, GTT/GTC. ATG and TGG were used for methionine and tryptophan, respectively. The sequence was thoroughly analyzed for repeated sequences and strong secondary structures by using the SEARCH program in IntelliGenetics software and these characteristics were completely avoided in the overlapping regions by changing to the next preferred codon. Since restriction sites were introduced only at the ends, the coding sequences were not affected. The gene was designed with an EcoRI and BamHI site at the 5' end and a BamHI site at the 3' end. The gene was divided into a total of 40 oligonucleotides ranging in length from 32 to 60 bases. The overlap between the oligonucleotides was 6-9 bases. Our choice for the length of oligonucleotides was based mainly on two considerations: (i) to take advantage of current DNA synthesis capability and (ii) to provide minimum sequence errors in gene synthesis and cloning. Our prior experience has led us to believe that oligonucleotides 50-70 bases long satisfy these two criteria quite well (unpublished data). Based also on our previous experience, we used 6-to 9-base overlaps between the oligonucleotides.
Effects of Reaction Conditions on PCR Amplifications. We observed that the optimal concentrations for PCR amplifications of ligation mixtures were 2.5 mM MgCl2 and 500 AM dNTPs. The maximum concentrations studied were 10 mM MgCG2 and 1.5 mM dNTPs. Higher concentrations of Mg2+ and dNTPs showed only a slight decrease in the intensity of product bands on agarose gels whereas lower concentrations indicated significant differences. We did not find any significant difference in amplifications as analyzed by gel electrophoresis when 2-10 units of the Taq enzyme was used. A denaturation temperature of 94°C was optimal. Thirty cycles of amplification were used in most of the cases.
Single-Step Ligation and PCR. Initially we investigated the effects of (i) the number of oligonucleotides that can be ligated in a single step, (ii) the purity of oligonucleotides required, and (iii) the removal of the unligated oligonucleotides and unwanted ligation products on PCR amplifications of synthetic genes from crude ligation mixtures. As a result, ligation mixtures containing various numbers (from 1 to 40) of HRP oligonucleotides were used for the PCR. The quantity of oligonucleotides in these ligation mixtures was either 0.25 pmol or 25 pmol. We also tested gel-purified versus gel-filtered oligonucleotides. Centricon filtration of ligation mixtures was also done in some cases to test the effect of removing ligation products and unreacted oligonucleotides that are smaller in size than the expected product. Centricon-30 and Centricon-100 (molecular weight cut off, 30,000 and 100,000, respectively) were used in most of the cases.
The results on ligation and PCR amplification with various numbers of oligonucleotides are shown in Fig. 1 . The data indicate that as many as 40 oligonucleotides can be ligated simultaneously and, when used for PCR amplification, resulted in the synthesis and amplification of HRP gene. Although we did not find any difference in amplifications between gel-purified and gel-filtered oligonucleotide primers, the intensity of product bands could be increased sometimes by using gel-or HPLC-purified primers. PCR amplification of ligation mixtures containing gel-filtered oligonucleotides was equally successful as verified by the size of bands on the gel. As an example, ligation of crude oligonucleotides 1-14 is shown in Fig. 1, lane 9 . Only a smear could be seen on the gel before PCR amplification. After amplification a clear band for the product is seen (lane 10). Centricon filtration of ligation mixtures before the PCR did not affect the amplification results. We also found that 0.25 pmol of each oligonucleotide, when ligated and PCR-amplified, yielded the product as efficiently as the ligation and 1:100 dilution of 25-pmol reaction mixtures (Fig. 1, lanes 11 and 12) . Although there is no difference in the target concentration (10-13 to 10-15 M in both cases), there is at least a 100-fold savings in the quantity of oligonucleotides required in the latter case. It should be possible to use even lower concentrations ofoligonucleotides. However, it may not have much practical application since the oligonucleotides cannot currently be synthesized at such a low concentration.
Joining of EIRP Gene Fragments by PCR. In addition to developing a method for gene synthesis using a single-step 1 ligation followed by a PCR, we were also interested in developing a methodology in which PCR-generated products can be ligated in-frame and at the same time cloned using convenient restriction sites. Such a method will have direct application in gene synthesis and also can serve as a general method for precise fusion of DNA fragments of interest. We were able to develop such a method using primers that contained class IIS restriction enzyme recognition sequences. Examples are described with HRP fragments containing Fok I restriction enzyme recognition sequences, although other enzymes in class IIS family may be used.
The recognition sequence and the cleavage sites for this enzyme are separated by 9 bases on one strand and 13 bases on another strand and the enzyme does not discriminate the base sequences in this region as shown below:
T Because of lack of specificity in this region, we were able to introduce additional restriction sequences such as EcoRI and BamHI. The sequences of the two PCR primers were also chosen such that the cohesive ends produced after Fok I cleavage were compatible with the ends of the fragments to be ligated. This is illustrated with examples of PCR primer sequences designed for cloning and ligating HRP fragments 1, 2, and 3. Fragment HRP2 was amplified from a ligation mixture containing oligonucleotides 13- Proc. Natl. Acad. Sci. USA 88 (1991) Ligation of sequences 1 and 2 produced a 630-bp fragment with a sequence as follows:
The HRP1 fragment was amplified from the ligation mixture containing oligonucleotides 1-14 by using HRP1 and HRP1F1 as primers. The primer sequences were HRP1 (5'-GGATCCGAATTCATAATGCAATTGACTCCAACTTTC-TACG-3') and HRP1F1 (5'-AGGATGCGAATTC-CCCCAAGGTGACGCTTTGTTGAGC-3'). The amplified HRP1 product was treated with Fok I and ligated to the 630-bp fragment shown above to produce the gene. The gene was also made by ligating all the three PCR-amplified fragments simultaneously after Fok I treatment. The results of amplifications using these primers and the final assembly of the gene are also shown in Fig. 2 . As expected, we were also able to generate the gene by carrying out amplification on a sample of ligation mixture containing all three Fok I-treated fragments. Individual fragments (HRP1, 2, and 3) were cloned as EcoRI-BamHI fragments and sequenced. The gene was also synthesized from HRP fragments by yet another strategy. In this strategy, the HRP fragments were PCR-amplified such that the fragments produced would have overlapping sequences. For example, HRP1 was amplified from oligonucleotides 1 to 14, HRP2 was amplified from oligonucleotides 13 to 26, and HRP3 was amplified from oligonucleotides 25 to 40. Fragments HRP1 and HRP2 share oligonucleotides 13 and 14 whereas fragments HRP2 and HRP3 share oligonucleotides 25 and 26. The fragments were ligated separately from the corresponding number of oligonucleotides using appropriate primers. The ligation mixtures were then filtered through Centricon-30 filters and 1-,ul samples of these ligation reaction mixtures were then combined and PCR-amplified with primers 1 and 40. Alterna- 1 2 3 4 5 6 7 8 9 10 FIG. 2. Joining of HRP gene fragments in-frame by PCR using primers containing Fok I restriction enzyme recognition sequences and fragments containing overlapping sequences. PCR products were analyzed on a 4% agarose gel. Lanes: 1, Msp I digest of pBR322 DNA; 2, ligation and PCR amplification of HRP oligonucleotides 1-14 (group 1) using HRP1 and HRP1F1 as primers; 3, ligation and PCR amplification of HRP oligonucleotides 13-26 (group 2) using HRP2F2 and HRP2F3 as primers; 4, ligation and PCR amplification of HRP oligonucleotides 27-40 (group 3) using HRP3F4 and HRP40 as primers; 5, ligation of PCR products from HRP groups 1, 2, and 3 after Fok I treatment; 6, ligation and amplification of HRP oligonucleotides 13-26 using HRP13 and HRP26 as primers; 7, ligation and amplification of HRP oligonucleotides 25-40 using HRP25 and HRP40 as primers; 8, ligation and amplification of HRP oligonucleotides 1-14 using HRP1 and HRP14 as primers; 9, PCR amplification of ligation and PCR amplification mixtures of oligonucleotides 1-14, 13-26, and 25-40 using HRP oligonucleotides 1 and 40; 10, Hae III digest of OX174 DNA.
tively, individual fragments were first amplified, the PCR products were filtered through Centricon-30, and then 1-Al samples were combined and used for PCR amplification using primers 1 and 40. This approach is similar to gene splicing by the overlap extension method (9) .
Cloning and Sequencing of the Gene and Its Fragments. After the preliminary confirmation (of the product by PCR, as shown in Fig. 3) , the gene fragments were cloned as described earlier and then sequenced either manually or by using the automated sequencer. We had no difficulty in obtaining clones that contained the correct sequences in all the cases. After several attempts to clone the gene in DH5a, DH5aF', and HB101, by using pUC18, pUC19, pUC119, and pBluescript vectors, we finally obtained a few clones of the HRP gene from HB101 cells. To check whether the problem in cloning was unique to the PCR-generated product, the gene was also synthesized by current procedures (without use of the PCR). Cloning of this gene product was equally difficult. The difficulty in cloning the gene can be attributed to the toxicity of HRP gene product to the host cells. The fact that fragments up to 660 bp have been cloned without any difficulty supports this interpretation. It may also be consistent with the finding (10) that it is necessary to delete C-terminal portions of a synthetic HRP gene to obtain expression in E. coli.
DISCUSSION
The essential feature of our PCR-mediated gene synthesis approach is that the entire gene is synthesized and purified in a single step by using the PCR. All the oligonucleotides making up the gene are annealed and ligated and the crude ligation mixture is used as the target for PCR amplification of the gene from this mixture using the two extreme end oligonucleotides as primers. synthesis. Although the small quantity of oligonucleotides required in this method may not appear to be an advantage for the synthesis of shorter oligonucleotides (30-to 50-mers), it will become a crucial factor when longer oligonucleotides are used. Even synthesis reactions with very low yields can provide enough material for this procedure. It may be possible to use even smaller quantities of oligonucleotides but at present even the lowest scale of synthesis can produce sufficiently large quantities ofthe oligonucleotides. (iii) Since sufficient quantities of the gene can be generated by PCR, it can be sequenced directly without cloning. However, no information on error rate can be obtained. This point is particularly valuable when the synthetic gene may be toxic to the cells (as may be the case with HRP gene) and so cannot be cloned easily and sequenced. (iv) Mutants of the synthetic gene can also be generated in a single step by substituting an appropriate set of oligonucleotides in the ligation/amplification mixture.
The size of the PCR products obtained from a single-step ligation can be increased by increasing the length of individual oligonucleotides (>100-mers) without increasing the number of oligonucleotides or by increasing both the number and the length of oligonucleotides. Although this single-step ligation followed by a PCR procedure should be applicable to larger genes, we were interested in devising a strategy whereby gene fragments are first generated by PCR and then joined together in-frame. The size of the gene fragments could be larger than 1 kilobase. Our strategy involved the use of primers containing class IIS restriction enzyme recognition sequences such as Fok I and is illustrated in Fig. 2 . The advantage of our approach is that the PCR-generated fragments using these primers can be ligated in-frame after Fok I digestion or can be cloned into a suitable vector after digestion with restriction enzymes whose recognition sequences have been inserted between the Fok I recognition and cleavage sites. Alternatively, vectors containing Fok I restriction sites can be used to directly clone these fragments also. The HRP gene was synthesized from three HRP gene fragments by using this strategy. The gene fragments were also joined together in-frame by generating fragments containing overlapping sequences. The disadvantage of this procedure is that the fragments could not be cloned directly. The use of primers containing Fok I restriction enzyme sequences can be a general method offusing DNA sequences precisely and can also be exploited for site-directed mutagenesis except when both fragments contain internal Fok I recognition sequences. If one of the fragments contains an internal Fok I recognition sequence, the sequence of the primer containing an additional Fok I recognition site should be designed carefully such that the cleavage sites for both Fok I sites are identical. This has been illustrated for HRP2. If both fragments contain internal Fok I recognition sites, then one of sites has to be removed during the design of the gene.
The error rates introduced by Taq polymerase have been documented in several reports (11) (12) (13) and are a major drawback in any PCR-related approach. The error rate depends on reaction conditions, number of starting molecules, and the sequence. Conditions for high-fidelity DNA synthesis by Taq polymerase have also been defined (14) . The main concern in gene synthesis may arise from rearrangement of oligonucleotides due to spurious ligations when several oligonucleotides are ligated simultaneously. Another cause for concern is that the oligonucleotides themselves may contain a small population of heterogeneous sequences in spite of extensive purifications. The latter problem is common to any gene synthesis methodology. Sequencing results of cloned PCR fragments indicate that the products obtained from our PCR approach do contain the expected arrangement of oligonucleotides and that the sequences of the products were exactly as expected. A majority of the observed errors (about 80%) were deletions. Since Taq polymerase-induced errors are known to be mostly base substitutions (11, 13, 14) , it is very likely that the errors in our DNA sequences may be due more to the heterogeneity of oligonucleotides than to problems with the fidelity of Taq polymerase. Based on these sequence data and from our experience in gene synthesis using conventional procedures, we feel confident that the PCR-based approach does not introduce additional errors compared with conventional gene synthesis procedures. The Mg2+ ion and triphosphate concentration requirements for our PCR approach are well within the range of conditions that promote high-fidelity DNA synthesis by Taq polymerase (14) . If the HRP gene product is toxic to the host cells, they may select against the correct coding sequence during cloning. Therefore, a true representation of the error rate cannot be obtained. We also encountered similar cloning problems with the HRP gene generated by conventional procedures.
Cloning and expression of synthetic as well as natural HRP isozyme c (isolated from HRP) have been attempted recently. Expression of the natural HRP was not successful in E. coli (15) but the synthetic gene was reported to have been expressed as an inactive protein (10, 16) . The enzyme activity was restored by reconstituting with heme and Ca2+ ions (16) .
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